Preparation and biological evaluation of [61Cu]bleomycin complex as a possible PET radiopharmaceutical in normal and fibrosarcoma-bearing animals

Nukleonika

Volumn 54, Issue 2, 2009, Pages 135-141

  Jalilian, Amir R ^a   Zandi, Hassan ^b   Sardari, Daryoush ^a,b   Akhlaghi, Mehdi ^a   Kamali Dehghan, Mohsen ^a   Shafaei, Kamaleddin ^a   Majdabadi, Abbas ^a  

^a AGRICULTURAL MEDICAL AND INDUSTRIAL RESEARCH SCHOOL   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Bleomycin; Copper 61; Fibrosarcoma; Positron emission tomography; Radiopharmaceutical

Indexed keywords

EID: 77954806629     PISSN: 00295922     EISSN: 15085791     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antholine WE, Solaiman D, Saryan LA, Petering DH. (1982) Studies on the chemical reactivity of copper bleomycin. J Inorg Biochem 11:75-94
2. Bereman RD, Winkler ME. (1980) A spectral investigation of the copper complex of the antitumor compound bleomycin. J Inorg Biochem 13:95-104
3. Brooks RC, Carnochan P, Vollano JF et al. (1999) Metal complexes of bleomycin: evaluation [Rh-105]--bleomycin for use in targeted radiotherapy. Nucl Med Biol 26:421-430
4. DiGiovanni J, Rymer J, Slaga TJ, Boutwell RK. (1982) Anticarcinogenic and cocarcinogenic effects of benzo[e] pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons. Carcinogenesis 3:371-375
5. 61Cu-BLM. Radiochim Acta 92:209-214
6. Hoehn ST, Junker HD, Bunt RC, Turner CJ, Stubbe J. (2001) Solution structure of Co(III)-bleomycin-OOH bound to a phosphoglycolate lesion containing oligonucleotide: implications for bleomycin-induced double-strand DNA cleavage. Biochemistry 22:5894-5905
7. Jaaskela-Saari HA, Kairemo KJ, Ramsay HA, Grenman R. (1998) Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines. Int J Radiat Biol 73:565-570
8. 62Zn]bleomycin as a possible PET tracer. Nukleonika 50:143-148
9. 64Cu]-DOTA-anti-CD20 for targeted therapy. J Radioanal Nucl Chem 274:563-568
10. 66Ga]bleomycin complex as a possible PET radiopharmaceutical. J Radioanal Nucl Chem 264:617-621
11. 61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies. Appl Radiat Isot 64:337-341
12. 201Tl] (III)-bleomycin for tumor imaging. Radiochim Acta 94:453-459
13. Korppi-Tommola T, Huhmar H, Aronen HJ et al. (1999) 111In-labelled bleomycin complex for the differentiation of high- and low-grade gliomas. Nucl Med Commun 20:145-152
14. Lewis JS, Sharp TL, Laforest R, Fujibayashi Y, Welch MJ. (2001) Tumor uptake of copper-diacetyl-bis(N4-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med 42:655-661
15. Litaka Y, Nakamura H, Nakatani T et al. (1978) Chemistry of bleomycin. XX. The X-ray structure determination of P-3A Cu(II)-complex a biosynthetic intermediate of bleomycin. J Antibiot (Tokyo) 31:1070-1072
16. Ma DF, Lu T, Overstreet DE, Milenic M, Brechbiel W. (2002) Novel chelating agents for potential clinical applications of copper. Nucl Med Biol 29:91-105
17. McCarthy DW, Bass LA, Cutler PD et al. (1999) High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol 26:351-358
18. Martindale (Rittenhouse Book Distributors) (1996) Bleomycin monograph. The Extra Pharmacopoeia, 31st ed. Vol. 1, pp 546-547
19. Melnyk DL, Horwitz SB, Peisach J. (1987) The oxidation--reduction potential of copper-bleomycin. Inorgan Chim Acta 138:75-78
20. Nunn AD, Lunec J. (1978) A comparison of the effect of metal-bleomycin complexes on the DNA damage and survival of cultured mammalian cells. Eur J Cancer 14:857-863
21. Rowshanfarzad P, Jalilian AR, Kyomarsi M et al. (2006) Production, quality control and initial imaging studies of [82mRb]Rbcl for PET studies. Nukleonika 51:209-215
22. Rowshanfarzad P, Sabet M, Jalilian AR, Kamali-Dehghan M. (2006) An overview of copper radionuclides and production of 61Cu by proton irradiation of natZn at a medical cyclotron. Appl Radiat Isot 64:1563-1573
23. Stern PH, Halpern SE, Hagan PL, Howell SB, Dabbs JE, Gordon RM. (1981) Cytotoxic activity, tumor accumulation and tissue distribution of ruthenium-103-labeled--bleomycin. J Nat Cancer Inst 66:807-811
24. Takita T, Umezawa Y, Saito SI et al. (1982) Retro-synthetic manipulation of bleomycins. Tet Lett 123:521-524
25. Welwyn, H. (1973) Proceedings of 1st Int Symp on Bleomycin. London, Lundbeck Ltd